According to recent sequencing efforts, NRAS, KRAS, and TP53 mutations are the main drivers of myeloma evolution at the single nucleotide level, resulting in an additional level of complexity [13,14,15,16]. The gene discussed is NRAS; the disease is plasma cell myeloma.